HORIZON PHARMA PLC's ticker is HZNPXXXX and the CUSIP is G4617B105. A total of 201 filers reported holding HORIZON PHARMA PLC in Q2 2016. The put-call ratio across all filers is 0.33 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $395,000 | +45.2% | 14,933 | +7.2% | 0.02% | +20.0% |
| Q4 2018 | $272,000 | -0.4% | 13,933 | 0.0% | 0.02% | +15.4% |
| Q3 2018 | $273,000 | +18.2% | 13,933 | 0.0% | 0.01% | +18.2% |
| Q2 2018 | $231,000 | +16.7% | 13,933 | 0.0% | 0.01% | +22.2% |
| Q1 2018 | $198,000 | -2.5% | 13,933 | 0.0% | 0.01% | 0.0% |
| Q4 2017 | $203,000 | +6.8% | 13,933 | 0.0% | 0.01% | 0.0% |
| Q3 2017 | $190,000 | +15.2% | 13,933 | 0.0% | 0.01% | +12.5% |
| Q2 2017 | $165,000 | -19.9% | 13,933 | 0.0% | 0.01% | -20.0% |
| Q1 2017 | $206,000 | -8.4% | 13,933 | 0.0% | 0.01% | -9.1% |
| Q4 2016 | $225,000 | -11.1% | 13,933 | 0.0% | 0.01% | -21.4% |
| Q3 2016 | $253,000 | +22.2% | 13,933 | +10.8% | 0.01% | +7.7% |
| Q2 2016 | $207,000 | – | 12,572 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 5,664,219 | $83,717,000 | 10.14% |
| Consonance Capital Management LP | 6,218,903 | $91,915,000 | 9.63% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 10,944,988 | $161,767,000 | 6.24% |
| Rhenman & Partners Asset Management AB | 1,751,322 | $25,885,000 | 4.10% |
| SCOPIA CAPITAL MANAGEMENT LP | 9,686,262 | $143,163,000 | 2.64% |
| ARMISTICE CAPITAL, LLC | 850,000 | $12,563,000 | 2.59% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 2,959,258 | $43,738,000 | 2.40% |
| Proxima Capital Management, LLC | 246,311 | $3,640,000 | 2.22% |
| Beach Point Capital Management LP | 522,898 | $7,728,000 | 2.18% |
| GRAYBILL WEALTH MANAGEMENT, LTD. | 165,260 | $2,443,000 | 1.94% |